Obalon Therapeutics OBLN shares spiked about 30 percent following circulation of a Food and Drug Administration AccessData.gov document for the weight loss Obalon balloon system.
The Obalon Balloon System is a swallowable intragastric balloon system indicated for temporary use to facilitate weight loss in adults with obesity.
Obalon Therapeutics traded at $1.47 per share at time of publication, up 12 percent.
Related Link:
Obalon Closes Above $1 Following Questionable Takeover Rumor
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
